{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:21:07Z","timestamp":1773181267090,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1554,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis & Rheumatism"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1002\/art.30308","type":"journal-article","created":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T16:00:44Z","timestamp":1298736044000},"page":"1527-1533","source":"Crossref","is-referenced-by-count":43,"title":["Extra domain A of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through activation of Toll-like receptor 4"],"prefix":"10.1002","volume":"63","author":[{"given":"Julie S.","family":"Lefebvre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"L\u00e9vesque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Picard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Par\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Gravel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Flamand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Borgeat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"key":"10.1002\/art.30308-BIB1|cit1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1084\/jem.20052371","article-title":"Neutrophil-derived leukotriene B4 is required for inflammatory arthritis","volume":"203","author":"Chen","year":"2006","journal-title":"J Exp Med"},{"key":"10.1002\/art.30308-BIB2|cit2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1084\/jem.20052349","article-title":"A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis","volume":"203","author":"Kim","year":"2006","journal-title":"J Exp Med"},{"key":"10.1002\/art.30308-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1084\/jem.185.6.1123","article-title":"Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice","volume":"185","author":"Griffiths","year":"1997","journal-title":"J Exp Med"},{"key":"10.1002\/art.30308-BIB4|cit4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1073\/pnas.92.2.517","article-title":"Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis","volume":"92","author":"Griffiths","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/art.30308-BIB5|cit5","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.4049\/jimmunol.176.10.6254","article-title":"Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice","volume":"176","author":"Shao","year":"2006","journal-title":"J Immunol"},{"key":"10.1002\/art.30308-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/art.23597","article-title":"CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis","volume":"58","author":"Grespan","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30308-BIB7|cit7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/art.1780380516","article-title":"EDA-containing fibronectin is synthesized from rheumatoid synovial fibroblast-like cells","volume":"38","author":"Hino","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30308-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.2388","article-title":"New insights into form and function of fibronectin splice variants","volume":"216","author":"White","year":"2008","journal-title":"J Pathol"},{"key":"10.1002\/art.30308-BIB9|cit9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1189\/jlb.1206730","article-title":"The extra domain A of fibronectin stimulates murine mast cells via Toll-like receptor 4","volume":"82","author":"Gondokaryono","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1002\/art.30308-BIB10|cit10","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1074\/jbc.M100099200","article-title":"The extra domain A of fibronectin activates Toll-like receptor 4","volume":"276","author":"Okamura","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1002\/art.30308-BIB11|cit11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.4049\/jimmunol.178.2.748","article-title":"The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo","volume":"178","author":"Lasarte","year":"2007","journal-title":"J Immunol"},{"key":"10.1002\/art.30308-BIB12|cit12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/ar2729","article-title":"Toll-like receptors and NOD-like receptors in rheumatic diseases","volume":"11","author":"McCormack","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1002\/art.30308-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1002\/art.27590","article-title":"Protective targeting of high mobility group box chromosomal protein 1 in a spontaneous arthritis model","volume":"62","author":"Ostberg","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30308-BIB14|cit14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1096\/fj.09-135624","article-title":"Toll-like receptor ligands induce polymorphonuclear leukocyte migration: key roles for leukotriene B4 and platelet-activating factor","volume":"24","author":"Lefebvre","year":"2010","journal-title":"FASEB J"},{"key":"10.1002\/art.30308-BIB15|cit15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/jlb.59.5.709","article-title":"Priming of human peripheral blood mononuclear cells with lipopolysaccharides for enhanced arachidonic acid release and leukotriene synthesis","volume":"59","author":"Surette","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1002\/art.30308-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1084\/jem.186.8.1401","article-title":"Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils","volume":"186","author":"Krump","year":"1997","journal-title":"J Exp Med"},{"key":"10.1002\/art.30308-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1096\/fj.06-7457com","article-title":"The Toll-like receptor 7\/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-activating factor biosynthesis","volume":"21","author":"Hattermann","year":"2007","journal-title":"FASEB J"},{"key":"10.1002\/art.30308-BIB18|cit18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/136.4.469","article-title":"Inhibition of the biologic effects of endotoxin on neutrophils by polymyxin B sulfate","volume":"136","author":"Bannatyne","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1002\/art.30308-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1476-5381.2009.00297.x","article-title":"Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model","volume":"157","author":"Takashima","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1002\/art.30308-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1124\/mol.105.019695","article-title":"A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits Toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling","volume":"69","author":"Ii","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1002\/art.30308-BIB21|cit21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cellimm.2005.04.018","article-title":"The role of Toll-like receptor signalling in the pathogenesis of arthritis","volume":"233","author":"Brentano","year":"2005","journal-title":"Cell Immunol"},{"key":"10.1002\/art.30308-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1002\/art.21273","article-title":"RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3","volume":"52","author":"Brentano","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30308-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1002\/art.22848","article-title":"Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis","volume":"56","author":"Abdollahi-Roodsaz","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30308-BIB24|cit24","first-page":"614","article-title":"Characterization of inflammatory mediator release from purified human lung mast cells","volume":"133","author":"Schleimer","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1002\/art.30308-BIB25|cit25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-065X.2007.00512.x","article-title":"Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation","volume":"217","author":"Boyce","year":"2007","journal-title":"Immunol Rev"}],"container-title":["Arthritis & Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.30308","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/art.30308\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T21:36:50Z","timestamp":1625089010000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.30308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,31]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1002\/art.30308","relation":{},"ISSN":["0004-3591"],"issn-type":[{"value":"0004-3591","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,31]]}}}